Bill C-51 and Natural Health Products - The Facts
|
|
- Beverly Tate
- 5 years ago
- Views:
Transcription
1 Bill C-51 and Natural Health Products - The Facts 1. How will Bill C-51 change the way natural health products are regulated? Bill C-51 will not affect the way that natural health products are regulated in Canada. The Natural Health Product Regulations, introduced in 2004, will continue to operate the same way under the proposed Bill C-51. Bill C-51 has been drafted to complement and support current policies for natural health products. The Natural Health Product Regulations already recognize that natural health products are different from drugs, and that the evidence requirements for drugs are not appropriate for natural health products. Bill C-51 does not change this. In fact, Bill C-51 supports different requirements for different types of products. Therefore, the standards that are used to assess the risks and benefits of natural health products will continue to incorporate history of use, traditional uses and cultural practices. The regulated activities for natural health products have already been identified in the Natural Health Product Regulations, and do not change. These regulated activities are: manufacturing, packaging, labelling, importation and distribution of natural health products for sale. Revisions to the list of controlled activities in Bill C-51 are only for cells, tissues and organs. For natural health products, compliance and enforcement activities will continue to be guided by the Compliance Policy for Natural Health Products and the Health Products and Food Branch Inspectorate's Policy This means that any future decision to take action will continue to be based on the same risk-based principles used today: the higher the risk to human health and safety posed by a natural health product, the more immediate the compliance and enforcement action. 2. Why is it necessary to regulate natural health products? The legislation requires vigilance to ensure that tainted products are found and recalled, that what is on the label is actually in the bottle, and that health claims are supported by evidence. Health Canada often issues warnings about mislabelled products or products that have serious adverse reactions. For example, diethylene glycol was found in fluoridated toothpaste and liver toxicity has been associated with the use of a Black cohosh product that was found to contain a species of the plant different than the one stated on the label. We have also seen cases where a natural health product makes a completely unfounded health claim- the ability to cure cancer or SARS for example. In addition, the increasing import of products and ingredients from foreign countries will require oversight to assure product safety and quality for Canadians.
2 3. Why aren t natural health products regulated and legislated as foods? The Natural Health Products Regulations were developed based on the recommendations of the Standing Committee on Health. During the development of the Regulations, the vast majority of stakeholders indicated that they did not want natural health products regulated as foods. 4. Will Bill C-51 cause the price of natural health products to rise? No. Under Bill C-51, Canadians will continue to have access to natural health products that are safe, effective and of high quality. The Bill will not limit access to natural health products nor should it increase their costs as it does not call for a change to the way in which these products are regulated. 5. Will jobs be lost or will the supply of natural health products be restricted by Bill C-51? Under Bill C-51, Canadians will continue to have access to natural health products that are safe, effective and of high quality. The Bill will not limit access to natural health products nor does it call for a change in their regulatory status (from over-the-counter to prescription). 6. Will I still be able to get my natural health product at my local health food store under Bill C-51? Yes. Canadians will continue to have access to natural health products that are safe, effective and of high quality. The Bill does not apply to retail sale of natural health products and therefore will not alter consumers ability to access products. 7. Will naturopathic doctors and other health care practitioners have continued access to the products they need to assist their clients? Yes. Bill C-51 does not target practitioners who compound products for their patients. 8. Is Bill C-51 targeting natural health products practitioners or consumers? No, the activities of natural health products practitioners falls under provincial jurisdiction. Personal use of products by consumers is also not affected by Bill C-51. The regulated activities for natural health products are already identified in the Natural Health Products Regulations, and remain unchanged. These activities are: manufacturing, packaging, labelling, importation and distribution of natural health products for sale. The new definition of sale in Bill C-51 will not affect practitioners. The relationship between practitioner and patient for compounding falls under the definition of practice of medicine and is under provincial jurisdiction. Bill C-51 respects this arrangement.
3 9. What harm/safety issues justify the Natural Health Products Regulations? The Natural Health Products Regulations are the Government of Canada s response to the Standing Committee on Health s 1997 report Natural Health Products: A New Vision. In its report, the Standing Committee recommended that a unique regulatory framework for natural health products, separate from the Food and Drug Regulations, be created. These recommendations were made following a thorough analysis of consumer use of natural health products as well as the way in which these products were being regulated at the time (as drugs under the Food and Drug Regulations). While natural health products are generally low risk, Health Canada has addressed a number of health and safety issues relating to natural health products, as was found with adulterated products such as the prescription drugs benzodiazepines in sleep aids and sildenafil in herbal products for erectile dysfunction. There have been substitution problems as was found with diethylene glycol in fluoridated toothpaste, and incorrect plants being used in a Black Cohosh product (which are for relief of the symptoms of menopause). Also, where good manufacturing practices have not been respected, there have been safety issues around bacterial contamination, and the presence of heavy metals, including arsenic and lead. Infants, children and the elderly are particularly vulnerable to these types of contamination. 10. How will Bill C-51 impact manufacturers/suppliers of, and thereby my access to, professional caliber therapeutic products? Bill C-51 will not impact the way in which natural health products are regulated in Canada. Manufacturers and importers of natural health products will continue to be subject to the same regulatory requirements they have been subject to since the implementation of the Natural Health Products Regulations in January The definition of therapeutic products in the Bill is fairly broad. Natural health products are not really mentioned, where do they fall within this broad definition and is there a way to be more distinct within it? Under Bill C-51 the term therapeutic products encompasses a range of products sold for therapeutic purposes, including drugs, medical devices, biologics, and natural health products. This does not change the classification of a natural health product nor impose additional requirements. The Government is proposing amendments to the Bill that would define Natural Health Products, and would separate NHPs from drugs under the umbrella of therapeutic product. This would ensure that the third category of NHPs is created in the legislation. Deleted: ill Deleted: will 12. Does Bill C-51 require natural health product manufacturers, importers, packagers and labellers to obtain an establishment license instead of a site license?
4 No, Bill C-51 does not change the requirements for site licensing of the natural health product industry. The requirements for a natural health product site license remain consistent with the Natural Health Products Regulations. This applies to natural health product manufacturers, importers, labellers and packagers. The term establishment license is an umbrella term that is used in Bill C-51 to support a number of different types of licenses that are required to manufacture products. Bill C- 51 will allow different types of establishment licenses to be created, including site licenses for natural health products, and site registration for other products. These existing licensing systems will not change. 13. Will a health food store require a special license to sell natural health products? No. The Natural Health Products Regulations do not impose product licence requirements on retailers. The controlled activities covered by the Regulations include: manufacturing, packaging, labelling and importation of natural health products for commercial sale and distribution in Canada 14. Does section 15.1(4) of this Bill give the power to designate therapeutic products as drugs? Could natural health products be swept into the class of 'drugs' and require prescription given this power? Under the current Food and Drugs Act, products are either classified as drugs, cosmetics foods, or medical devices. Natural health products are presently classified as a subset of drugs, but have their own unique regulatory framework (the Natural Health Products Regulations) separate from the regulatory regime for drugs (the Food and Drug Regulations) The Government is proposing an amendment to the Bill that would distinguish natural health products from drugs. This would ensure that NHPs could not be classified as drugs. 15. I am afraid that by lumping natural health products into the broad definition of "therapeutic products" used in the Bill, that the line will become blurred between natural therapeutics and drugs. As an ND, I cannot prescribe drugs. Thus, I fear that in future, I may lose my rights to prescribe vital nutrients, herbs and remedies to patients. Bill C-51 will not impact the way in which natural health products are regulated in Canada. While classified as therapeutic products under the Bill, natural health products will continue to be regulated under their own regulatory system - the Natural Health Products Regulations - which is separate from the regulatory system for drugs. There is nothing in Bill C-51 that changes the regulatory status of natural health products from over-the-counter, as they are now, to prescription. Under Bill C-51, Canadians will
5 continue to have access to natural health products that are safe, effective and of high quality. Natural health products would continue to be classed as therapeutic products because they make health claims, and because the Government does not wish NHPs to become subject to the international Codex Alimentarius. Deleted: ill 16. Since the introduction of the Natural Health Products Regulations, is there an example of a natural health product being converted to a prescription drug? No. Since the Natural Health Products Regulations came into force in 2004, there have been no amendments to convert a product from a natural health product to a prescription drug. 17. What licensing will be required under Bill C-51 to permit a mother to give her child a tablet of vitamin C? No licence whatsoever will be required. The Bill does not target the personal use of natural health products by Canadians, including mothers who give natural health products to their children. 18. Do Natural Health Products require DIN numbers? No they do not. Natural health products require a Natural Product Number (NPN) or, in the case of homeopathic medicines, a Homeopathic Medicine Number (DIN-HM) in order to be legally sold in Canada. This requirement has been in place since January 1, 2004 under the Natural Health Products Regulations. The evidence requirements under the Natural Health Products Regulations are flexible, and different from those relating to DIN drugs. The standards that are used to assess the risks and benefits of natural health products will continue to incorporate history of use, traditional uses and cultural practices. 19. Is there a way to appeal a decision made by Health Canada regarding the licensing of a natural health product? Sections 9(2) and 9(3) of the Natural Health Products Regulations provide stakeholders with the option to request that the Department, on behalf of the Minister of Health, reconsider its decision to refuse to issue or amend a product license. 20. Does Bill C-51 push natural health products under the same laws as prescription drugs? Natural health products will continue to be regulated as over-the-counter products under the Natural Health Products Regulations, which have been in force since January 1, 2004.
6 21. Will changes to the Food and Drugs Act result in a ban on natural health products? Will this change mean a prescription will be required for natural health products, like Vitamin C? No. There is nothing in Bill C-51 that changes the regulatory status of natural health products from over-the-counter, as they are now, to prescription. Under Bill C-51, Canadians will continue to have access to natural health products that are safe, effective and of high quality. Natural health products will continue to be regulated in the same way under the Natural Health Product Regulations, which have been in force since January 1, Why does Bill C-51 change the definition of sell and how will this impact small natural health product business owners? Under Bill C-51, the definition of sell is amended to provide clarity with respect to distribution and leasing activities. These clarifications would mainly apply to cells, tissues and organs and to medical devices. These changes do not impact natural health products. 23. What is the future under Bill C-51 for supplements and will there be regulated doses? Will 100mg tablets of vitamin C be available and allowed without prescription? The Bill will not limit access to natural health products nor does it call for a change in their regulatory status (from over-the-counter to prescription). Under Bill C-51, Canadians will continue to have ready access to a wide range of over the-counter natural health products, including vitamin and mineral supplements of various doses and levels. Allowable dosage levels for all natural health products will continue to be determined by the evidence provided to support their safety and efficacy. 24. What impact will Bill C-51 have on the prescribing relationship between a naturopathic doctor and their patient? No impact whatsoever. Bill C-51 does not target practitioners who compound products for their patients and respects the practitioner-patient relationship. The practice of medicine falls within provincial jurisdiction. 25. If Bill C-51 passes, will this mean that ALL or most therapeutic products will need a prescription from a doctor? No. Bill C-51 does not change the classification of a natural health product nor impose
7 additional requirements such as changing their status from over-the-counter to prescription. 26. How will Bill C-51 impact clinical trials? The requirements for conducting clinical trials involving natural health products are outlined in the Natural Health Products Regulations, which have been in force since January 1, Bill C-51 will not change the manner in which clinical trials for natural health products are reviewed and authorized by Health Canada. 27. Will the increased enforcement powers, fines and penalties in Bill C-51 lead to more compliance action against natural health product companies? Updates to the Act will not result in more compliance and enforcement action taken for regulated products, including natural health products. A modernized Act will allow Health Canada to undertake more effective compliance and enforcement activities by providing the Department with the authority to act based on a product's level of risk. The fact is that the current compliance and enforcement portions of the Food and Drugs Act are over 50 years old and need to be updated. Canada lags significantly behind other parts of the world in this area, especially the United States, Europe, and Australia. The compliance and enforcement proposals will allow us to respond to risks, regardless of the product type - they will not result in more enforcement action taken against natural health products or any other regulated product. In fact, the approach to compliance and enforcement activities for natural health products will stay the same, and will continue to be guided by the Compliance Policy for Natural Health Products and the Health Products and Food Branch Inspectorate's Policy Any decision to take action will be based on the same risk-based principles that are used today: the higher the risk posed by a product, the more immediate the compliance and enforcement action. However, further amendments are being proposed by the Government that would ensure that inspectors use their powers in a reasonable way, gauging their enforcement actions according to the degree of risk of the product. Deleted: to ensure 28. Does Bill C-51 allow inspectors to go into private homes at will? No. If an inspector needed to enter a private home, they would have to have the owner's consent or, after making a compelling case to a judge, a warrant to enter. There is nothing in Bill C-51 that changes this. Some manufacturing sites may not be situated on public roads or beside public spaces. The Bill contains a provision that would permit inspectors to cross private property to gain access to a manufacturing site. This provision does not, in any way, permit an inspector to enter a private home without consent or a warrant.
8 Section 23 of the Bill sets out very clearly the requirements for a warrant to enter a dwelling house. 29. Why is it necessary to have such a dramatic increase in fines and penalties? While fines under Bill C-51 have increased, the highest fines are intended to be applied for the most severe contraventions. A minor contravention would not be treated in the same manner as an incident that has significant impacts on the health and safety of Canadians. For instance, in dealing with cases of counterfeit, Health Canada has been limited to imposing a maximum fine of $5,000. This is in comparison with other jurisdictions where fines for similar contraventions have been in excess of $5,000,000. Canada's fines and penalties structure is over 50 years old and is significantly behind modern international regulatory authorities such as the United States, Europe, Australia and New Zealand. Canadians deserve the same protections as citizens of other countries. An increase in fines and penalties will deter companies who do not intend to comply with the Food and Drugs Act and its Regulations. The increase is meant to emphasize the importance of maintaining the integrity of the Canadian supply chain, which all Canadians rely on for safe health products. 30. Since there is a backlog in approvals for natural health products, will the natural health products that are not approved be subject to the seizure and fine powers under Bill C-51? The Natural Health Products Regulations are enforced pursuant to the Compliance Policy for Natural Health Products, which employs a risk-based approach to enforcement. Compliance and enforcement action will be taken if the natural health product has not been issued a submission number or the product has been identified as posing an unacceptable risk to the health and safety of Canadians. For more information on the Compliance Policy for Natural Health Products, please visit this website: Can Health Canada seize your bank account? No. This authority does not currently exist in the Act nor is it included in Bill C Will inspectors be able to levy fines up to five million dollars or seek two years in jail for the suspect? No. Inspectors cannot levy fines or sentence people to terms in prison. As is currently the case under the Food and Drugs Act, only those regulated parties who are prosecuted and found guilty through the judicial process are subject to the fines and penalties provisions of the Food and Drugs Act. Accordingly, such fines and imprisonment terms can only be
9 applied by the courts. 33. How many inspectors will Health Canada, Canadian Food Inspection Agency and the Canadian Border Services Agency have because of Bill C-51? Bill C-51 itself does not increase the number of inspectors for Health Canada, the Canadian Food Inspection Agency or the Canadian Border Services Agency. 34. If a natural health product is licensed to do one thing and a naturopathic doctor tells me to use it for another issue, am I or the naturopathic doctor committing a crime? No you are not committing a crime. Bill C-51 does not target the health care practitioner/patient relationship or the personal use of products by consumers. However, Health Canada always encourages consumers to use products in accordance with the label instructions or to seek the advice of a health care practitioner prior to offlabel use (i.e. using a product for a reason other than what is indicated on the label). 35. What happens if a natural health product is deemed to be dangerous and the retailer will not remove it from the shelves? A product that has been determined by way of scientific assessment to be dangerous, and which the retailer nevertheless chooses to leave on the shelves would pose a serious and imminent risk to health and safety and, as such, would warrant risk mitigation steps. Accordingly, and consistent with the Health Products and Food Branch Inspectorate s Policy-0001, Compliance and Enforcement Policy, Health Canada would seize such a product. 36. Does the Minister of Health own any shares in a pharmaceutical company? No. 37. Will Bill C-51 interfere with our Charter rights? No. 38. Why should Health Canada be able to decide what a Natural Health Product can or cannot say in regards to claims of health benefit? Health Canada s mission is to help the people of Canada maintain and improve their health. Part of this includes having appropriate checks in place to help ensure that the natural health products Canadians use are safe, effective and of high quality and also that products are labelled accordingly and truthfully (including any warnings or cautions) so that Canadians can make safe and informed choices. Having a unique set of regulations for natural health products allows for them to be
10 considered within appropriate parameters, and allows for health claims to be made based on evidence that is appropriate for these kinds of products. 39. If someone wants to take a natural health product in a way that is not approved by Health Canada, but has worked for them in the past, why can t that person make the decision that s right for them? Bill C-51 will in no way impact the way in which consumers choose to use products. However, Health Canada always encourages consumers to use products in accordance with the label instructions or to seek the advice of a health care practitioner prior to offlabel use (i.e. using a product for a reason other than what is indicated on the label). 40. Is Bill C-51 going to impact the rules surrounding growing an herb garden? No. Growing is not a regulated activity under Bill C-51 s controlled activities. 41. Will Bill C-51 impact my ability to hold a pot-luck dinner? No. If you have any questions, or comments on the proposed Action Plan and/or the proposed legislation changes, please contact us by or by calling
Understanding the New Access to Cannabis for Medical Purposes Regulations
Understanding the New Access to Cannabis for Medical Purposes Regulations Health Canada August 2016 Table of Contents 1. Introduction 2. Health Canada's role 3. What it means for health care practitioners
More informationM I L L E R T H O M S O N LLP Barristers & Solicitors, Patent & Trade Mark Agents
M I L L E R T H O M S O N LLP Barristers & Solicitors, Patent & Trade Mark Agents Communiqué for Health Industry Clients on the Legal Retainer Program Canada s New Natural Health Products Regulations On
More informationAmending Your Land Use Bylaw To Prepare For The Retail Sale Of Cannabis
1 Amending Your Land Use Bylaw To Prepare For The Retail Sale Of Cannabis The Federal Government has proposed that by July 2018 non -medical cannabis will be legalized in Canada. Currently, cannabis possession
More informationQuestions or comments regarding the content of the NHPD Monthly Communiqué may be addressed to
The NHPD Monthly Communiqué is a publication of Health Canada s Natural Health Products Directorate (NHPD), the federal department responsible for the regulation of natural health products sold in Canada.
More informationCannabis Legalization August 22, Ministry of Attorney General Ministry of Finance
Cannabis Legalization August 22, 2018 Ministry of Attorney General Ministry of Finance Federal Cannabis Legalization and Regulation The federal Cannabis Act received Royal Assent on June 21, 2018 and will
More informationCoversheet: Medicinal cannabis: 100 day action
Coversheet: Medicinal cannabis: 100 day action Advising agencies Decision sought Proposing Ministers Ministry of Health Introduction of Misuse of Drugs Amendment Bill Hon Dr David Clark, Minister of Health
More informationLegalization of Cannabis- Overview
Legalization of Cannabis- Overview Presentation to Regional Council Education Workshop February 15, 2018 Joy Hulton, Regional Solicitor 1 Overview Background Federal Cannabis Framework Provincial Legislation
More informationB.C. Cannabis PRIVATE RETAIL LICENSING GUIDE Applications and Operations
B.C. Cannabis PRIVATE RETAIL LICENSING GUIDE Applications and Operations Copyright February 2018, Province of British Columbia. All rights reserved. This material is owned by the Government of British
More informationCounterfeit Medicinal Products. FINLAND Roschier, Attorneys Ltd.
Counterfeit Medicinal Products FINLAND Roschier, Attorneys Ltd. CONTACT INFORMATION Mikael Segercrantz Robert Hagelstam Roschier, Attorneys Ltd. Keskuskatu 7 A 00100 Helsinki, Finland 358.20.506.6000 mikael.segercrantz@roschier.com
More informationThe Government is Claiming Victory for the Natural Health Community
Draft Discussion Paper on the Amendments to Bill C-51 Bill C-51 was debated during second reading in the week ending June 13, 2008. During second reading the Government introduced amendments to the Bill.
More informationPlanning For The FDA s 'Deeming Rule' For E- Cigarettes
Law360, New York (September 21, 2015, 3:39 PM ET) -- The 2009 Family Smoking Prevention and Tobacco Control Act (TCA)[1] gave the U.S. Food and Drug Administration the authority to oversee the manufacture,
More informationConsultation on legislation for the sale of tobacco products and non-medicinal nicotine delivery system, including e-cigarettes
Consultation on legislation for the sale of tobacco products and non-medicinal nicotine delivery system, including e-cigarettes Policy Group on Tobacco Jan 2015 1 Table of contents Background... 2 Policy
More informationCannabis Legalization Proposed Bylaws
2018 April 03 Page 1 of 7 EXECUTIVE SUMMARY On 2017 April 13, the Government of Canada introduced Bill C-45, An Act respecting cannabis and to amend the Controlled Drugs and Substances Act, the Criminal
More informationProposed Amendments to the Cannabis Regulations: Edible Cannabis, Cannabis Extracts and Cannabis Topicals
Proposed Amendments to the Cannabis Regulations: Edible Cannabis, Cannabis Extracts and Cannabis Topicals Health Canada s 2019 Regulatory Consultation 1 Purpose The purpose of this presentation is to provide
More informationDiscussion points on Bill S-5
Disclaimer: The following document was developed to provide a brief set of discussion points for individuals wishing to discuss Bill S-5 with policy makers, politicians, senators or their advisers. It
More informationCannabis Legalization and Regulation in British Columbia Discussion Paper
Cannabis Legalization and Regulation in British Columbia Discussion Paper Introduction In 2015, the federal government committed to legalizing non-medical cannabis in Canada. On June 30, 2016, it established
More informationReview of Controlled Drugs and Substances Act
Review of Controlled Drugs and Substances Act Canadian Medical Association: Submission to Health Canada in response to the consultation on the Controlled Drugs and Substances Act and its regulations A
More informationAn Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis. February 2018
An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis February 2018 I m here today to provide 1 2 3 Context for the Government of Canada s plan to legalize,
More informationAn Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis
An Overview of the Government of Canada s Approach to Legalize, Regulate and Restrict Access to Cannabis I m here today to provide 1 2 3 Context for the Government of Canada s plan to legalize, regulate
More informationProposed Excise Duty Framework for Cannabis Products
Department of Finance Canada Proposed Excise Duty Framework for Cannabis Products 1. Introduction and Purpose The Government of Canada is committed to providing regulated and restricted access to cannabis,
More informationCannabis Retail Store Licensing in Ontario. General Committee December 10, 2018
1 Cannabis Retail Store Licensing in Ontario General Committee December 10, 2018 Item 1 Item 2 Item 3 Item 4 Item 5 Item 6 Item 7 Item 8 Item 9 Item 10 Item 11 Item 12 Presentation Outline Federal Regulatory
More informationImpact Summary: Therapeutic Products Bill Personal Import of Medicine by mail/courier
Impact Summary: Therapeutic Products Bill Personal Import of Medicine by mail/courier Section 1: General information Purpose The Ministry of Health is solely responsible for the analysis and advice set
More informationLegalization and Regulation of Recreational Cannabis PRESENTATION LPPANS NOVEMBER 22, 2017
Legalization and Regulation of Recreational Cannabis PRESENTATION LPPANS NOVEMBER 22, 2017 2 2 Purpose for Today Review: Timeline Overview of Federal Legislation Consultation update Next Steps 3 Nova Scotia
More informationQUESTIONS AND ANSWERS
QUESTIONS AND ANSWERS LEGISLATION When will the changes come into force? The Government hopes to have the bill passed into law before the end of this parliamentary term. It s anticipated that most changes
More informationFood and Drug Regulations - Project Number Schedule F
Graham Spry Building 250 Lanark Avenue Address Locator: 2005D Ottawa, Ontario K1A 0K9 09-128254-482 Provincial and Territorial Deputy Ministers of Health Provincial and Territorial Drug Program Managers
More informationJanuary 19, Cannabis Legalization and Regulation Secretariat Address locator 0602E Health Canada Ottawa, Ontario K1A 0K9
January 19, 2018 Cannabis Legalization and Regulation Secretariat Address locator 0602E Health Canada Ottawa, Ontario K1A 0K9 By email: cannabis@canada.ca RE: Proposed Approach to the Regulation of Cannabis
More information1. Introduction. 2. Role of PSI as Pharmacy Regulator
1. Introduction 1.1. I would like to begin by thanking the Committee for inviting the Pharmaceutical Society of Ireland here today to assist in the Committee s on-going scrutiny of the Cannabis for Medicinal
More informationLegalization of Recreational Cannabis
Legalization of Recreational Cannabis Private Recreational Cannabis Retail Storefronts December 11, 2018 History of Cannabis Legalization April 13, 2017 Federal Bill C-45, otherwise known as the Cannabis
More informationA Family Medicine Cabinet
A Family Medicine Cabinet What is a medicine? There is no generally accepted definition for the word medicine. Most people use the word medicine to refer to products that affect how the body functions.
More informationThe Nutrition (Amendment) (EU Exit) Regulations 2018
The Nutrition (Amendment) (EU Exit) Regulations 2018 A public consultation Contents Introduction... 3 Why we are consulting... 4 Nutrition and Health Claims... 6 Proposals... 6 Vitamins, minerals, and
More informationRE: CONSULTATION ON DRAFT - DRUG AND NATURAL HEALTH PRODUCTS RECALL GUIDE
January 14, 2019 Health Products Compliance and Enforcement Unit Regulatory Operations and Regions Branch Health Canada By email to: hc.hpce-cpsal.sc@canada.ca RE: CONSULTATION ON DRAFT - DRUG AND NATURAL
More informationGuidance for Industry DRAFT GUIDANCE. This guidance document is being distributed for comment purposes only.
Compounded Drug Products That Are Essentially Copies of a Commercially Available Drug Product Under Section 503A of the Federal Food, Drug, and Cosmetic Act Guidance for Industry DRAFT GUIDANCE This guidance
More informationThe Marketing of a Food Ingredient Understanding a System that has Worked for 105 Years
The Marketing of a Food Ingredient Understanding a System that has Worked for 105 Years Gary L. Yingling Food Policy Impact December 2011 Copyright 2011 by K&L Gates LLP. All rights reserved. Brief Historical
More informationCANNABIS RETAIL & PRODUCTION OPERATIONS PROPOSED REGULATIONS
CANNABIS RETAIL & PRODUCTION OPERATIONS PROPOSED REGULATIONS ` Table of Contents Background:... 2 Regulatory Tools:... 4 Zoning:... 4 Cannabis Retail Zoning... 5 Cannabis Production Operations Zoning...
More informationRecall Guidelines. for Chinese Medicine Products
Recall Guidelines for Chinese Medicine Products April 2018 Recall Guidelines for Chinese Medicine Products Chinese Medicines Board Chinese Medicine Council of Hong Kong Compiled in September 2005 1 st
More informationRe: Bill S-5, An Act to amend the Tobacco Act and the Non-smokers Health Act and to make consequential amendments to other Acts
655 Third Avenue, 10th Floor, New York, NY 10017-5646, USA t: +1-212-642-1776 f: +1-212-768-7796 inta.org esanzdeacedo@inta.org The Honorable Kelvin Kenneth Ogilvie Chair Standing Committee on Social Affairs,
More informationPolicy Options for the Regulation of Electronic Cigarettes
Policy Options for the Regulation of Electronic Cigarettes Consultation submission This submission was completed by: (name) Position (if applicable): Evon Currie General Manager, Community and Public Health
More informationRegulatory Impact Statement. The International Convention on Standards of Training, Certification and Watchkeeping 1978
Regulatory Impact Statement Introducing a Blood Alcohol Limit for On-duty Seafarers The International Convention on Standards of Training, Certification and Watchkeeping 1978 Agency disclosure statement
More informationDate Marking. User Guide. Standard Date Marking of Food. December 2013
Date Marking User Guide to Standard 1.2.5 Date Marking of Food December 2013 Contents Contents... ii Background... 1 Food Standards in Australia and New Zealand... 1 Responsibility of food businesses...
More informationperpetuate -- and perhaps even intensify -- that controversy. 1 On July 18th, the Fifth Circuit affirmed FDA s longstanding position that
Food & Drug July 29, 2008 Fifth Circuit Rules that FDA May Regulate Compounded Drugs as New Drugs Update on Medical Center Pharmacy v. Mukasey For decades, the pharmacy compounding industry has disputed
More informationFACT SHEET PREPARED BY THE MINISTRY OF JUSTICE ON THE DANGEROUS DRUGS (AMENDMENT) ACT 2015 OVERVIEW 1. This Fact Sheet sets out the main changes that have been made to the Dangerous Drugs Act (the DDA
More informationWritten Brief to the Standing Committee on Health
Canadian Association of Chiefs of Police Association canadienne des chefs de police Written Brief to the Standing Committee on Health C-45 - An Act respecting cannabis and to amend the Controlled Drugs
More informationExplanatory Notes Relating to Regulatory and Legislative Proposals Relating to the Taxation of Cannabis
Explanatory Notes Relating to Regulatory and Legislative Proposals Relating to the Taxation of Cannabis Published by The Honourable William Francis Morneau, P.C., M.P. Minister of Finance September 2018
More informationProposed Radiation Safety Regulations: Submission form
Proposed Radiation Safety Regulations: Submission form Making a submission This form is designed to assist submitters responding to the discussion points in Proposed Radiation Safety Regulations: A consultation
More informationProvincially-Licensed Cannabis Retail Stores in Toronto
CC1.4 REPORT FOR ACTION Provincially-Licensed Cannabis Retail Stores in Toronto Date: December 6, 2018 To: City Council From: City Manager Wards: All SUMMARY Provincially-licensed private cannabis retail
More informationCHE8000 Major Research Project A. The Complementary Medicines Reforms and Its Impact to the Complementary Medicine Industry and the Consumer
CHE8000 Major Research Project A The Complementary Medicines Reforms and Its Impact to the Complementary Medicine Industry and the Consumer Completed by: Lina Karlina (ID: 2067226) Lina Karlina (2067226)
More informationProf. Stefania Negri Jean Monnet Chair in European Health, Environmental and Food Safety Law
Prof. Stefania Negri Jean Monnet Chair in European Health, Environmental and Food Safety Law SSFFC drugs are medical products that: do not contain any specific active substances, irrespective of the indication
More informationThe North American Metal Packaging Alliance
The North American Metal Packaging Alliance About NAMPA NAMPA News May 22, 2009 Volume 2, Issue 2 The North American Metal Packaging Alliance, Inc. (NAMPA) is committed to promoting sound science in risk-based
More informationCannabis: SCRD Land Use Regulations. Infrastructure Services Committee Presentation June 2018
Cannabis: SCRD Land Use Regulations Infrastructure Services Committee Presentation June 2018 Direction THAT staff prepare a workshop for Rural Area Directors with regards to current Land Use regulations
More informationCMA Response: Health Canada s Medical Marihuana Regulatory Proposal. Submitted to the Office of Controlled Substances Health Canada.
CMA Response: Health Canada s Medical Marihuana Regulatory Proposal Submitted to the Office of Controlled Substances Health Canada February 28, 2013 A healthy population and a vibrant medical profession
More informationMARIJUANA LEGALIZATION. INITIATIVE STATUTE.
PROPOSITION MARIJUANA LEGALIZATION. OFFICIAL TITLE AND SUMMARY Legalizes marijuana under state law, for use by adults 21 or older. Designates state agencies to license and regulate marijuana industry.
More informationNatural Health Product Raw Material Policy
Natural Health Product Raw Material Policy Natural Health Products Directorate Health Products and Food Branch October 2006 Health Canada is the Federal department responsible for helping Canadians maintain
More informationGOC GUIDANCE FOR WITNESSES IN FITNESS TO PRACTISE COMMITTEE HEARINGS
GOC GUIDANCE FOR WITNESSES IN FITNESS TO PRACTISE COMMITTEE HEARINGS The purpose of this guidance document The purpose of this guidance is to explain what happens if you are asked by the General Optical
More informationLegalization of Cannabis: The Way Forward
Percent 2018/05/03 Legalization of Cannabis: The Way Forward W. O. McCormick Academic Day Hon. A. Anne McLellan, PC, OC, AOE Friday, April 27 2018 Current Context 40 Past year cannabis use, by age group,
More information(English text signed by the State President) as amended by
TOBACCO PRODUCTS CONTROL ACT 83 OF 1993 [ASSENTED TO 23 JUNE 1993] [DATE OF COMMENCEMENT: 1 FEBRUARY 1994] (English text signed by the State President) as amended by General Law Fifth Amendment Act 157
More informationPsychoactive Substances (Increasing Penalty for Supply and Distribution) Amendment Bill
Psychoactive Substances (Increasing Penalty for Supply and Distribution) Amendment Bill 16 1 Report of the Justice Committee September 2018 Contents Recommendation... 2 About the bill as introduced...
More informationMitch Zeller, Director, Center for Tobacco Products, FDA September 19, 2013 Kansas Public Health Association
Regulatory Public Laws Compliance & Education Policies Science & Enforcement & Communications The FDA Center for Tobacco Products (CTP): Its Role in Reducing Tobacco Use Mitch Zeller, Director, Center
More informationDIRECT ACCESS - Guidance to BSDHT Members
DIRECT CCESS - Guidance to BSDHT Members Direct ccess came into effect from 1 May 2013. But what does it mean for dental hygienists and dental therapists? The GDC have published guidance notes on the subject
More informationORDER OF THE LIEUTENANT GOVERNOR IN COUNCIL
PROVINCE OF BRITISH COLUMBIA ORDER OF THE LIEUTENANT GOVERNOR IN COUNCIL Order in Council No. 542, Approved and Ordered October 5, 2018 Executive Council Chambers, Victoria On the recommendation of the
More informationCOMMISSION IMPLEMENTING DECISION. of
EUROPEAN COMMISSION Brussels, 26.7.2016 C(2016) 4592 final COMMISSION IMPLEMENTING DECISION of 26.7.2016 concerning national provisions notified by Finland prohibiting the placing on the market of certain
More informationCannabis, the law, and housing
Cannabis, the law, and housing Lauren Blumas, Iler Campbell LLP lblumas@ilercampbell.com December 6, 2017 Overview The medical marijuana framework right now Recreational cannabis - impending legalization
More informationUpdate on the Legalization and Regulation of Cannabis. January 8, 2018 Regular Meeting of Delta Council
Update on the Legalization and Regulation of Cannabis January 8, 2018 Regular Meeting of Delta Council Regulatory Authority for Cannabis Federal authority: Cultivation & Manufacturing Licensing, inspection,
More informationTobacco Free Ireland Action Plan
Tobacco Free Ireland Action Plan Tobacco Free Ireland, the report of the Tobacco Policy Review Group, was endorsed by Government, and published in October 2013. It builds on existing tobacco control policies
More informationMedical Devices. SOUTH AFRICA Bowman Gilfillan
Medical Devices SOUTH AFRICA Bowman Gilfillan CONTACT INFORMATION Llewellyn Parker Bowman Gilfillan PO Box 785812, Sandton, 2146 South Africa +27 11 669 9635 l.parker@bowman.co.za www.bowman.co.za 1. Definition
More informationCOUNTERFEIT DRUGS IN INDIA
COUNTERFEIT DRUGS IN INDIA a part presentation from the on-going dissertation Global Threat of Counterfeit Drugs A Study Covering Extent of Problem and Anticounterfeit Measures in Europe & India By, Viraj
More informationNew regulatory requirements DPCS Regulations 2017
New regulatory requirements DPCS Regulations 2017 Prescribers and pharmacists May 2017 Table of Contents Explanatory notes... 1 Clarifying the meaning of key terms... 1 Chart instructions and prescriptions...
More informationLegalization, Regulation and Restriction of Access to Cannabis
Legalization, Regulation and Restriction of Access to Cannabis Presentation to UNSM May 26th, 2017 Departments of Justice, Health and Wellness and Finance and Treasury Board Today Origin and Federal Context
More informationFundamentals of Pharmacology for Veterinary Technicians Chapter 1
1906 1914 1933 1937 1938 1941 1951 1965 1968 1970 1970 1972 1972 1983 1984 1988 1994 1994 1996 1997 2001 2003 2008 The original Pure Food and Drug Act is passed by Congress on June 30 and signed by President
More informationREGULATORY REGISTRY FEEDBACK FORM. Proposed Places of Use Regulations under the Cannabis Act, 2017
REGULATORY REGISTRY FEEDBACK FORM Proposed Places of Use Regulations under the Cannabis Act, 2017 The Ontario government would like your feedback on regulatory proposals related to where cannabis can be
More informationDevelopments in regulations for complementary medicines (including traditional medicines and other natural health products)
Developments in regulations for complementary medicines (including traditional medicines and other natural health products) A/Professor Jo Barnes BPharm (Hons) PhD RegPharmNZ MPSNZ FLS School of Pharmacy,
More informationDriving and Epilepsy. When can you not drive? 1. Within 6 months of your last epileptic seizure.
Driving and Epilepsy Does epilepsy disqualify you from driving? It is important to note that having epilepsy does not automatically disqualify you from being legally permitted to drive in Ontario. In fact,
More informationRE: Permits under the Arizona Pharmacy Act should not be required for dietary supplements
Board Members Arizona State Board of Pharmacy 1616 W. Adams St., Suite 120 Phoenix, AZ 85007 c/o Kam Gandhi, PharmD Executive Director Arizona State Board of Pharmacy Via email: kgandhi@azpharmacy.gov
More informationCannabis use carries significant health risks, especially for people who use it frequently and or/begin to use it at an early age.
Background: The Centre for Addiction and Mental Health (CAMH) released recommendations for the Legalization of Marijuana (with restrictions and regulations) on October 8, 2014. Addiction Services of Thames
More informationIndustry s Perspective on the Status of Medical Device Regulations. FUNDISA Workshop 09 & 10 Oct Anele Vutha SAMED Regulatory Committee
Industry s Perspective on the Status of Medical Device Regulations FUNDISA Workshop 09 & 10 Oct 2014 Anele Vutha SAMED Regulatory Committee Today s Topics: 1. Medical Device Definition - Differences 2.
More informationHealth Authority Abu Dhabi. Document Title: Policy for Recall of Drugs and Healthcare Products Document Ref. Number:
Health Authority Abu Dhabi Document Title: Policy for Recall of Drugs and Healthcare Products Document Ref. Number: PPR/DMP/DR/P0001 Version 0.9 Approval Date: August 2007 Effective Date: August 2007 Last
More informationFrequently Asked Questions
Frequently Asked Questions The Halton Regional Police Service, in collaboration with the Region of Halton Health Department, has created a collection of Frequently Asked Questions (FAQ) regarding how Bill
More informationNHPD Monthly Communiqué
NHPD Monthly Communiqué Vol. 3, Issue 5 February 2008 The NHPD Monthly Communiqué is a publication of Health Canada s Natural Health Products Directorate (NHPD), the federal department responsible for
More informationSubmission to the Senate Community Affairs Legislation Committee inquiry into the Therapeutic Goods Amendment (2016 Measures No.
Submission to the Senate Community Affairs Legislation Committee inquiry into the Therapeutic Goods Amendment (2016 Measures No. 1) Bill 2016 Submitted by: Submitted electronically to: Complementary Medicines
More informationCANNABIS IN YOUR COMMUNITY. A Presentation to CPAA Conference May 2017
CANNABIS IN YOUR COMMUNITY A Presentation to CPAA Conference May 2017 WE LL BE THERE FOR YOUR HIGHS AND LOWS! Presented by: MUNICIPAL Charlotte A. St. Dennis Senior Associate Edmonton Office cstdennis@brownleelaw.com
More informationOFFICIAL STATE BULLETIN
No. 280 Saturday 18 November 2017 Sec. I. Page 111191 I. GENERAL PROVISIONS HEAD OF STATE 13277 Royal Decree-Law 17/2017, of 17 November, amending Law 28/2005, of 26 December, on health measures against
More informationREGULATORY CHALLENGES IN SOUTH AFRICA
REGULATORY CHALLENGES IN SOUTH AFRICA MEDICINES CONTROL COUNCIL SA Prof Peter Eagles Chairperson Medicines Control Council [Southern African Regional and International Symposium (SARI 2014)] 1 OUTLINE
More informationClassification of Products at the Food Natural Health Product Interface: Products in Food Formats
Classification of Products at the Food Natural Health Product Interface: Products in Food Formats Natural Health Products Directorate Food Directorate June 2010 Version 2.0 Health Canada is the Federal
More informationBorder Issues and Statistics: Regulatory Activities. Mr. Robert Deininger Southwest Import Director AFDO San Antonio, Texas
Border Issues and Statistics: Regulatory Activities Mr. Robert Deininger Southwest Import Director AFDO San Antonio, Texas U.S. Food & Drug Administration Mission Statement The Food & Drug Administration
More informationDRUG FREE WORKPLACE POLICY
GENERAL STATEMENT DRUG FREE WORKPLACE POLICY Kitsap County Government is obligated and committed to provide our employees and the citizens of Kitsap County with an alcohol and drug free, healthy, safe,
More informationTHE NEW CANADIAN NATURAL HEALTH PERODUCT REGULATIONS
THE NEW CANADIAN NATURAL HEALTH PERODUCT REGULATIONS IMPACT AND OPPORTUNITY FOR CHINESE MEDICINE JULY 2006 Yili Bai, PhD Tel: 604-249-2896 Email: ybai@wellgenex.com Michael ZC Li, MSc, MD, MBA Tel: 604-249-2896
More informationCannabis Legalization
Cannabis Legalization Meeting with Education Stakeholders October 26, 2018 Agenda 1. Welcome and Introductions (EDU) 2. Overview of Federal and Provincial cannabis legislation (MAG) 3. Overview of Licence
More informationCriminal Justice (Psychoactive Substances) Bill Regulatory Impact Analysis
Criminal Justice (Psychoactive Substances) Bill 2010 Regulatory Impact Analysis 1. Summary RIA Summary of Regulatory Impact Analysis (RIA) Department/Office: Department of Justice and Law Reform Stage:
More informationCannabis Regulations Response and Update on Cannabis Legalization
Page 1 of 5 EXECUTIVE SUMMARY On 2018 October 17, Bill C-45, The Cannabis Act, came into force legalizing non-medical cannabis in Canada. Non-medical cannabis is now legal in limited forms, including dried
More informationSPECIAL REPORT. BEHIND THE SCENES with a Former FDA Inspector
SPECIAL REPORT BEHIND THE SCENES with a Former FDA Inspector 34627 Copyright 2012 All Rights Reserved DISCLAIMER: This special report is intended for educational purposes only. Consumers should never disregard
More informationA COMMITTEE OF THE WHOLE MEETING WILL BE HELD IN THE MUNICIPAL COUNCIL CHAMBERS AT CITY HALL ON THURSDAY, NOVEMBER 16, 2017 AT 12:00 P.M.
A COMMITTEE OF THE WHOLE MEETING WILL BE HELD IN THE MUNICIPAL COUNCIL CHAMBERS AT CITY HALL ON THURSDAY, NOVEMBER 16, 2017 AT 12:00 P.M. A G E N D A A. COMMITTEE OF THE WHOLE 1. Danielle Myles, Economic
More informationSenate Bill No. 225 Senators Farley, Hardy, Harris, Gustavson, Atkinson; Goicoechea and Settelmeyer
Senate Bill No. 225 Senators Farley, Hardy, Harris, Gustavson, Atkinson; Goicoechea and Settelmeyer CHAPTER... AN ACT relating to crimes; prohibiting a person from selling, distributing or offering to
More informationQUESTIONS AND ANSWERS Access to Drugs in Exceptional Circumstances
QUESTIONS AND ANSWERS Access to Drugs in Exceptional Circumstances Published by authority of the Minister of Health Date Adopted 2017/06/09 Effective Date 2017/06/28 Health Products and Food Branch Our
More informationCOMPENDIUM OF MONOGRAPHS NATURAL HEALTH PRODUCTS DIRECTORATE
COMPENDIUM OF MONOGRAPHS NATURAL HEALTH PRODUCTS DIRECTORATE June 13 2013 Version 3.0 i FOREWORD Guidance documents are meant to provide assistance to industry and health care practitioners on how to comply
More informationGuidelines on the Sourcing of Medicinal Products for Sale or Supply by a Retail Pharmacy Business
Guidelines on the Sourcing of Medicinal Products for Sale or Supply by a Retail Pharmacy Business to Facilitate Compliance with Regulations 5(1)(g), 6, 8 and 11 of the Regulation of Retail Pharmacy Businesses
More informationResearch: Medical Cannabis
Research: Medical Cannabis Background The hemp plant Cannabis sativa (cannabis) is commonly known as marijuana and can be used as a therapy to alleviate symptoms such as pain and fatigue caused by chronic
More informationhttps://www.businesscompanion.info/en/quick-guides/food-and-drink
https://www.businesscompanion.info/en/quick-guides/food-and-drink Food & drink In the guide Food hygiene & safety Food safety: quality & composition Food safety: quality & labelling Prepacked food Best
More informationCOMMISSION OF THE EUROPEAN COMMUNITIES COMMISSION STAFF WORKING DOCUMENT
COMMISSION OF THE EUROPEAN COMMUNITIES Brussels, 23.11.2009 SEC(2009) 1621 final COMMISSION STAFF WORKING DOCUMENT Report on the implementation of the Council Recommendation of 2 December 2002 on the prevention
More informationCancer Council New South Wales: Submission on Public Health (Tobacco) Regulations 2016
Cancer Council New South Wales: Submission on Public Health (Tobacco) Regulations 2016 To whom it may concern, Thank you for the opportunity to submit on the Draft Public Health (Tobacco) Regulations 2016
More informationThe FDA Food Safety Modernization Act: The Key New Requirements
June 15, 2011 The FDA Food Safety Modernization Act: The Key New Requirements Executive Summary INSTITUTE FOR FOOD LAWS & REGULATIONS Michigan State University 140 G.M. Trout Building East Lansing, MI
More informationLAO PEOPLE S DEMOCRATIC REPUBLIC PEACE INDEPENDENCE DEMOCRACY UNITY PROSPERITY
LAO PEOPLE S DEMOCRATIC REPUBLIC PEACE INDEPENDENCE DEMOCRACY UNITY PROSPERITY President s Office No. 13/PO DECREE of the PRESIDENT of the LAO PEOPLE S DEMOCRATIC REPUBLIC On the Promulgation of the Law
More information